Lymphomas and oncolytic virus therapy

被引:4
作者
Alain, T
Thirukkumaran, C
Morris, DG
Urbanski, SJ
Janowska-Wieczorek, A
Lee, PWK
Kossakowska, AE
机构
[1] Univ Calgary, Canc Biol Res Grp, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Pathol, Calgary, AB T2N 1N4, Canada
[3] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada
[4] Calgary Lab Serv, Calgary, AB, Canada
[5] Tom Baker Canc Clin, Calgary, AB, Canada
[6] Univ Alberta, Dept Med, Edmonton, AB T6G 2M7, Canada
[7] Canadian Blood Serv, Edmonton, AB, Canada
来源
CLINICAL LYMPHOMA | 2003年 / 4卷 / 02期
关键词
autotransplant; cytotoxicity; G207; herpes virus; ONYX-015;
D O I
10.3816/CLM.2003.n.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are several well-documented cases in medical literature of the remission of leukemias and malignant lymphomas following natural human viral infections. In the hope of being able to reproduce these spontaneous tumor regressions, investigators have studied various viruses with distinct oncolytic properties. The first attempts to treat patients with oncolytic viruses took place > 80 years ago; however, it achieved little success. With modern technologies and current knowledge of viruses and cancer, there is an expectation for the discovery of efficient oncolytic viral therapies. This article will review the current knowledge of oncolytic viruses in relation to the treatment of lymphoma.
引用
收藏
页码:104 / 111
页数:8
相关论文
共 97 条
[81]   Adenovirus infection of primary malignant lymphoid cells [J].
Strair, RK ;
Sheay, W ;
Goodell, L ;
White, E ;
Rabson, AB ;
Medina, DJ .
LEUKEMIA & LYMPHOMA, 2002, 43 (01) :37-49
[82]   The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus [J].
Strong, JE ;
Coffey, MC ;
Tang, D ;
Sabinin, P ;
Lee, PWK .
EMBO JOURNAL, 1998, 17 (12) :3351-3362
[83]   Interferon-α resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression [J].
Sun, WH ;
Pabon, C ;
Alsayed, Y ;
Huang, PP ;
Jandeska, S ;
Uddin, S ;
Platanias, LC ;
Rosen, ST .
BLOOD, 1998, 91 (02) :570-576
[84]  
TAQI AM, 1981, LANCET, V1, P1112
[85]   Adenovirus vector-based purging of multiple myeloma cells [J].
Teoh, G ;
Chen, L ;
Urashima, M ;
Tai, YT ;
Celi, LA ;
Chen, DS ;
Chauhan, D ;
Ogata, A ;
Finberg, RW ;
Webb, IJ ;
Kufe, DW ;
Anderson, KC .
BLOOD, 1998, 92 (12) :4591-4601
[86]   Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation [J].
Thirukkumaran, CM ;
Luider, JM ;
Stewart, DA ;
Cheng, T ;
Lupichuk, SM ;
Nodwell, MJ ;
Russell, JA ;
Auer, IA ;
Morris, DG .
BLOOD, 2003, 102 (01) :377-387
[87]  
TYLER KL, 1996, FIELDS VIROLOGY, P1597
[88]  
VANBESIEN K, 1995, BONE MARROW TRANSPL, V15, P549
[89]  
Wagner LM, 2002, CANCER RES, V62, P5001
[90]   Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207 [J].
Walker, JR ;
McGeagh, KG ;
Sundaresan, P ;
Jorgensen, TJ ;
Rabkin, SD ;
Martuza, RL .
HUMAN GENE THERAPY, 1999, 10 (13) :2237-2243